Healthcare, lifestyle and well-being apps. Who am I sharing my data with and what for? by Beneito-Montagut, Roser
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Day 1: Tuesday, 10th May 2016 
  
 NEC Forum – Part I   
 
The Ethics of e-Health, with a particular focus on privacy and 
medicalisation 
 
 
10.00 – 11.05  Session Chair: Prof. dr. Dick Willems 
   
   Part 1: e-Health and privacy 
 
  10.15 – 10.40  
  Dr. Roser Beneito (Spain) 
“Healthcare, lifestyle and well-being apps. Who am I sharing my 
data with and what for?”  
 
  10.40 – 11.05  
  Eugenio Mantovani (Italy) 
“Data privacy in e-health in the light of the new EU data protection 
regulation” 
 
11.05 – 11.30  Coffee break 
 
11.30 – 12.20  Part  2: Medicalisation of young people by e-health 
 
 
   11.30 – 11.55  
   Prof. dr. Kjell Asplund (Sweden) 
   “Self-tracking– health promotion or narcissism?” 
 
 
   11.55 – 12.20  
   Prof. dr. Ignaas Devisch(Belgium) 
   “Living a healthy life. From autonomy to oughtonomy” 
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10.15 – 10.40 Dr. Roser Beneito (Spain) 
 
“Healthcare, lifestyle and well-being apps. Who am I sharing my data with and what for?”  
 
Abstract 
Today we can find healthcare, lifestyle and well-being 
applications – for smartphones, tablets, wearable 
devices - for a plethora of aspects: from monitoring 
pregnancy to checking on blood pressure. These apps 
are used in our everyday life and not only in medical 
settings. They hold the promise of enhancing, managing, 
predicting and improving our individual health and 
healthcare services. Today, anyone with a smartphone 
can share personal health related data with healthcare 
services and companies, as well as other organisations 
and individuals. While people use these applications social media companies harvest, archive 
and manage huge amounts of data –aka big data. These two issues – people sharing personal 
data and the harvest of these data – have serious implications for the way in which research 
on human subjects can be undertaken and for the ethical frameworks that regulate such 
research. Key concerns are privacy, anonymity and data management. This talk focuses on 
the ethical implications arising from the everyday life use of healthcare applications and the 
risks, challenges and threats of big data. It addresses three issues (1) collection, analysis and 
sharing of personalised social media data; (2) anonymity and (3) privacy in a context where 
people is encouraged to share their data.  
 
A model of social science research has emerged from the convergence of user/patient control 
over personal health information, social media, user-generated content and citizen science. 
The development of ethical frameworks in the context of the digital society is still in its 
infancy and we should critically engage in their development.  
 
Bio 
Spanish national living in the UK. Roser Beneito-Montagut (PhD) is a Lecturer in Digital Social 
Sciences in the School of Social Sciences at Cardiff University (UK). Her research specialises 
in social media and digital social sciences. Her current research interests include digital 
sociology, interpersonal relationships online, social media in later life; institutions and 
organisations use of digital technologies; and digital research methods (including ethics and 
digital data). She is also a member of the Interdisciplinary Internet Institute research group 
CareNet at the Open University of Catalonia. Prior to this she was senior lecturer at UOC and 
research fellow on a EU funded project exploring the role of Social Media and its adoption by 
public sector organisations for risk and crisis communication: “Disaster 2.0: Using Web 2.0 
applications and Semantic Technologies to strengthen public resilience to disasters.” –based 
at the Aston University (UK). 
 
4 
 
10.40 – 11.05 Eugenio Mantovani (Italy) 
 
“Data privacy in e-health in the light of the new EU data protection regulation”  
 
Abstract 
Any electronic health (e-health) application, good or 
service, entails the processing of personal data and a 
potential intrusion in the private sphere of individuals. 
In my presentation I intend to talk about the protection 
of the private sphere in the context of e-health, from the 
point of view of the right to personal data protection. I 
will, first, briefly describe and distinguish between the 
fundamental rights to privacy and data protection.  
 
I will subsequently mobilise the relevant legislative framework on data protection and 
the decisions of the European Court of Justice and the European Court of Human 
Rights, with a view of anticipating
1
 how a judge would decide a conflict concerning 
the processing of personal data in the context of e-health. As legislative framework I 
will briefly describe the relevant provisions contained in the newly enacted Regulation 
(EU) 2016/679, the General Data Protection Regulation (GDPR) repealing Directive 
95/46/EC of 1995. In the GDPR, the EU constitutional legislator codifies (and, as I 
will argue, cautiously innovates) the fair processing principles (data minimization), 
rules on the legitimacy of processing, on sensitive medical data, as well as the rights of 
data subjects, the obligations of data controllers, etc.  
In order to anticipate the implications of the law on data protection, I use a scenario–
case study in which conflicts over the use of personal health data are represented. For 
this exercise, I draw from a scenario in which a young mother, rampant professional, 
Diana, and her frail old father, Jacob, navigate their day accompanied by mobile, 
personal digital assistance (PDAs).
2
 Given time constraints, the legal analysis is 
restricted to conflicts concerning the use of consent as legitimising basis for data 
processing in e-health. The legal analysis will enable to draw some conclusive remarks 
about the way in which the law specifically seizes data privacy in e-health cases and to 
suggest avenues of future research.  
 
Bio 
Italian national living in Belgium, I am a member of the research group on Law 
Science Technology & Society studies (LSTS) at the Vrije Universiteit Brussels 
(VUB). My areas of research include: data protection in Health Care, legal issues 
related to eHealth and mHealth, as well as human rights law. My current research 
concerns the legal implications of autonomy in the context of information and ageing 
societies. I have worked on a number of EU projects that involved aspects related to e-
Health, such as MOVING LIFE and REACTION. I am currently involved in the e-
health project IRIS, funded by the Brussels Institute for Research and Innovation 
(INNOVIRIS).  
                     
1 Gloria González Fuster and Serge Gutwirth, ‘Ethics , Law and Privacy: Disentangling Law from 
Ethics in Privacy Discourse’, Ethics in Science, Technology and Engineering 2014 IEEE International 
Symposium (2014). 
2 The scenario is adapted from chapter one of Mireille Hildebrandt. Smart Technologies and the End (s) 
of Law: Novel Entanglements of Law and Technology (Edward Elgar Publishing, 2015),  p.7. 
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Part 2:  Medicalisation of young people by e-health 
 
11.30 – 11.55 Prof. dr. Kjell Asplund (Sweden) 
 
“Self-tracking– health promotion or narcissism?”  
 
Abstract 
After starting as a sect-like movement (Quantified Self), self-tracking 
has now become normalized. It has the potential to promote healthy 
behaviour, strengthen self-esteem, and would thus constitute a new 
approach in public health. It has long been used in healthcare, e.g. by patients with diabetes. 
Then, it may be seen as tool for alleviating disease and improving patient empowerment. 
Self-tracking may, however, also be an expression of narcissism. There is increased focus on 
the ”overquantified self”, provoking neurotic behaviour; the self-tracking device is a constant 
reminder of the disease. In the eyes the health care staff, the patient may be reduced to a 
collection of digits.  The data may be used for advertisers, employers, insurance companies 
and the judiciary system, raising questions on responsibility and integrity.  
 
Bio 
Chair of the Swedish Council on Medical Ethics, former Director General of the National 
Board of Health and Welfare and Chief Medical Officer of Sweden, former Professor of 
Medicine, Umea University and consultant at North Sweden University Hospital.  
 
11.55 – 12.20 Prof. dr. Ignaas Devisch (Belgium) 
 
“Living a healthy life. From autonomy to 
oughtonomy” 
 
Abstract 
E-health is supposed to support the autonomy of the 
individual because it invites us to make use of technology 
to help us through self-monitoring our health. Despite this 
starting point, self-monitoring can also lead to an ongoing 
evaluation of daily activities to their impact on our health (medicalization). Next to that, 
underneath the free invitation to make use of e-health, runs the imperative that not making 
use of it, is a kind of negligence in preventing oneself from getting sick. At that point, 
autonomy turns into ‘oughtonomy’. 
 
Bio 
PhD Ignaas Devisch is professor in Ethics, Philosophy and Philosophy of Medicine. He holds a 
position at Ghent University, department of Primary Care and Family Medicine, and is 
affiliated with BIG (Bioethics Institute Ghent) and Artevelde University College, Belgium and 
was researcher for five years at the Radboud University Nijmegen. He publishes in the fields 
of medical philosophy, philosophy and ethics.  
 
Research areas 
Philosophy of medicine (patient autonomy; responsibility; lifestyle; obesity; justice); ethics; 
His research focuses mainly on Autonomy, lifestyle and responsibility in healthcare. 
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Day 1: Tuesday, 10th May 2016  
 
NEC Forum – Part II 
 
Ethical questions raised by Dementia 
 
13.30 – 13.45 Session Chair: Prof. dr. Pim van Gool 
 
13.45 – 14.35 Part 1 (Plenary): Early diagnosis dementia 
 
13.45 – 14.10  
Prof. dr. Jonathan Montgomery  (United Kingdom) 
  “Ethical issues in dementia care and diagnosis” 
 
14.10 – 14.35 
Prof. dr. Carlo Caltagirone (Italy) 
  “Ethical issues in dementia care and diagnosis” 
 
14.35 – 15.00 Coffee break  
15.00 – 16.00 Part 2:  (Workshops): Caring for patients with dementia 
 
 Prof. dr. Jan C. Molenaar (Netherlands) 
“Dementia in the era of modern medicine”  
 
 Prof. dr. Cees Hertogh (Netherlands) 
“Reinventing nursing home care for people with dementia” 
 
16.00 – 17.00 Plenary discussion  
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13.45 – 14.10 Prof. dr. Jonathan Montgomery  (United Kingdom)  
 
“Ethical issues in dementia care and diagnosis” 
 
Abstract  
The Nuffield Council on Bioethics published a report in 
2009 on ethical issues raised by dementia, following public 
consultation and meetings with stakeholders including 
people with dementia, carers, and health professionals. 
This report put forward an ethical framework to support 
ethical judgements in the context of dementia. This talk 
will give an introduction to this framework and how it can 
be practically applied in the day to day care of people with dementia, with a particular focus 
on the issue of diagnosis. It will also outline the UK Prime Minister’s ‘Challenge on Dementia 
2020’ and the progress that is being made. 
 
Biography  
Jonathan Montgomery is Chair of the Nuffield Council on Bioethics and of the Health 
Research Authority, and a Professor of Health Care Law at University College London. His 
research work concerns health care law and also bioethics governance systems. His previous 
national chair roles include the Advisory Committee on Clinical Excellence Awards (2005-14) 
and the Human Genetics Commission (2009-12). He served as Chair of a number of local NHS 
boards in Hampshire and the Isle of Wight for over fifteen years up to March 2013. In this 
capacity he was responsible for the oversight of the provision of older persons mental health 
services and also commissioning health care for the local populations. 
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14.10 – 14.35 Prof. dr. Carlo Caltagirone (Italy) 
 
“Ethical issues in (early) diagnosing and treating Dementia”  
 
Abstract 
Dementia is a state of progressive cognitive decline owing to 
an organic pathology leading the patient to a progressive 
loss of their functional autonomy. There is now a consensus 
that research on diagnosis and treatment options should be 
focused on earlier disease stages before the full picture of 
dementia is reached. This approach would ultimately lead to 
improving patient’s quality of life and the course of the 
disease, but it also involves risks and gives rise to important questions in the field of personal 
identity and consciousness, pain treatment, artificial nutrition, socio-healthcare assistance 
and patient charge. 
 
Bio 
- Education and Training 
   2 Degree in Medicine and Surgery      Speciali a on in  eurology      Speciali a on in 
Psychiatry “Universit  Ca olica” in  ome 
- Positions 
from      to    2  ssistant Professor at the  eurological Clinic of the “Universit  Cattolica” 
in Rome – Policlinico Agostino Gemelli. 
From 1983 to 1993 Associated Professor at the Neurological Clinical of the University of Rome 
Tor Vergata. From 1994 to date Full Professor of Neurology at the University of Rome Tor 
Vergata. 
From 1992 to date is Director of the Research Laboratory of Clinical and Behavioural 
Neurology at Fondazione Santa Lucia in Rome 
From 2001 to date is Scientific Director at the Scientific Institute for Research, Hospitalization 
and Health Care “Fonda ione Santa Lucia” of  ome. 
From October 2014 is Director of Research Laboratories of Experimental Neurosciences at the 
CERC - European Centre for Brain Research, Rome 
From November 2015 is the pro-tempore Director of the Neurology Residency Training 
Program of the Tor Vergata University School of Medicine 
- Publications 
Author of more than 800 publications in the field of Neurology, Psychiatry, Neuroimaging, 
Molecular Biology, Clinical Neuropsychology and Neurorehabilitation with about 25.000 
citations and an H-index of 77 
- Grants 
PI of more than 30 projects funded by the Italian Ministry of Health (Ricerca Finalizzata), the 
Italian Ministry of University and Research (PRIN), as well as private Foundations 
- Memberships 
He is a member of numerous national and international scientific societies. Vice President of 
AIP (Associazione Italiana di Psychogeriatrics) member Board of Directors SIN (Italian Society 
of Neurology), former President of SI D M  Italian Society of  eurology for the Demen as , 
former President of SI     Societ  Italiana di  eurogeriatria), President of SIRAS (Italian 
Society of Highly Specialized Rehabilitation). From 2013 he is member of the National 
Committee for Bioethics of the Presidency of the Council of Ministers, President of the 
College of Professors of Neurology.  
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Caring for patients with dementia 
 
15.00 – 15.30 Prof. dr. Jan C. Molenaar (Netherlands) 
 
“Dementia in the era of modern medicine”  
 
Abstract 
Lifetime partner of Catharina F. Oosterbaan, diagnosed 
with  l heimer’s disease several years ago, professor 
emeritus Jan C. Molenaar relates some of their 
experiences that strikingly bring to light the impact of this 
insidious disease on one’s life. From the point of view of 
this informal caregiver: “Following its course from close by 
is frightening and brings you often at your wits’ end.” In 
the second part of the presentation the speaker – a 
medical man himself – reflects on his personal 
experiences against the background of what he thinks has 
happened over the years with medicine. 
 
Curriculum vitae of J. C. Molenaar 
Jan Christoffel Molenaar was born on a freezing cold Sunday morning, 19 June 1932 in  
Maassluis, the Netherlands, a small town on the River Nieuwe Waterweg.  
1938 – 1944 Primary school, Maassluis. 
1944 –   4  ‘ xtended primary school’, Maassluis. 
   1945 – 1950 Secondary school,  Vlaardingen. 
1950 – 1958 Medical study at the Free University Amsterdam. 
13th May 1958 Married to Catharina F. Oosterbaan, teacher 
1958 – 1959 Courses in preparation for a medical post in the tropics. 
1959 – 1962 Medical officer in Dutch New Guinea. 
1963 – 1968 Training in surgery, Free University Amsterdam hospital. 
1968 – 1969 Senior staff surgeon, Free University Amsterdam hospital. 
1969 –    0 Training in pediatric surgery, Sophia Children’s Hospital  otterdam. 
1970 – 1974 Founder and chief of a new department of Pediatric Surgery and first pediatric 
intensive care department in the Netherlands, Free University Amsterdam hospital. 
1970 – 1974 Reader in pediatric surgery, Free University Amsterdam. 
1974 –      Chief of the department of Pediatric Surgery, Sophia Children’s Hospital 
Rotterdam. 
1974 – 1976 Reader in pediatric surgery, Erasmus University Rotterdam. 
1976 – 1997 Professor of pediatric surgery, Erasmus University Rotterdam. 
2000 – 2005 Curator of the library and historical collections of the Dutch Journal of Medicine. 
1997 – now Guest staff member of the department of Cell Biology and Genetics, Erasmus MC 
Rotterdam with a special interest in the influence of the biosciences on society and the 
thinking of modern man. 
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15.30 – 16.00 Prof. dr. Cees Hertogh (Netherlands) 
 
“Reinventing nursing home care for people with dementia” 
 
Abstract 
Although the system of nursing home care in the 
Netherlands belongs to the best in the world, this sector 
has always struggled with a negative image and 
discussions on the quality of nursing home care are as old 
as the institute itself. In response to this, several 
perspectives on good nursing home care for people with 
dementia have been developed over the years. These will 
be discussed with a special and critical focus on the 
current ideology of normalization, that materializes itself 
in small scale living arrangements and dementia villages. A 
plea will be made for refocusing nursing home care for people with dementia on (geriatric) 
palliative care.  
 
Bio 
Cees M.P.M. Hertogh is professor of elderly care medicine & geriatric ethics at the 
department of General Practice & Elderly Care Medicine of the VU University Medical Center, 
Amsterdam. His research focuses on geriatric palliative care, geriatric rehabilitation and 
ethical issues in the care and treatment of vulnerable older people with multimorbidity. He 
also works at the National Institute for Public Health and the Environment (RIVM). He is 
editor of the Dutch Journal for Gerontology and Geriatrics (Tijdschrift voor Gerontologie en 
Geriatrie) and member of the Dementia Ethics Steering Committee of Alzheimer Europe. 
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Day 2: Wednesday 11th May, 2016 
 
  NEC Forum – Part III 
The future: technological and value innovations 
 
08.30 – 09.00 Entry and Coffee 
09.00 – 09.15 Session Chair: Prof. dr. Inez de Beaufort 
 
09.15 – 10.15 Part 1: Ethics of gene editing (development and use of the  
  CRISP/cas technology) 
 
  09.15 – 09.45  Dr. Annelien Bredenoord (Netherlands)  
  “The ethics of germline genome editing: a very short history’’ 
 
  09.45 – 10.15  Prof. dr. John Harris (United Kingdom) 
“Gene Editing, Future People and Future Worlds” 
10.15 – 10.45 Coffee break 
10.45 – 11.00 Intermezzo by  guitar-player Hafez Ismaili M’hamdi 
11.00 – 12.30 Part 2: Core values of the EU and the future 
   
Young researchers: 
  11.00 – 11.30  Dr. Saskia Nagel (Germany) 
“An era of (neuro-) technological self-shaping and imperatives of self-
determination - the value of autonomy support” 
 
  11.30 – 12.00  Dr. Loredana  Persampieri (Italy) 
“Reproductive tourism and surrogacy: new challenges for European values” 
 
  12.00 – 12.30  Dr. Eline Bunnik (Netherlands)  
“Nice to meet? Ethical issues surrounding efforts to facilitate early access to 
investigational drugs” 
 
 
12.30 – 12.35 Closing Remarks NEC 2016 
Prof. dr. Pauline Meurs, Chair Centre for Ethics and Health and Chair Council 
for Public Health and Society of the Netherlands 
 
12.35 – 14.00  Lunch and Depart 
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Part 1: Ethics of gene editing (development and use of the CRISP/cas 
technology) 
 
Dr. Annelien Bredenoord  
 
“The ethics of germline genome editing: a very short 
history’’ 
 
Abstract 
Since the advent of recombinant DNA technology in the 
1970s, genetic testing, selection and screening have been 
considered to be ethically justifiable and allowed under 
most jurisdictions, but genetic modification of the human 
germline has for many been an ethical line that should 
not be crossed. Germline modification encompasses any 
biomedical intervention that modifies the genome that a person can transmit to his or her 
child and the child’s entire lineage. Until recently, the technological tools that enable a 
viable path to realizing human germline modification were not available. However, two 
very recent scientific developments have revived the international discussion on the 
ethics of germline modification and underscore the need to address the ethics and 
governance of human germline modification now. 
First, UK parliament recently legalized a novel reproductive genetic technology to 
prevent mitochondrial DNA disorders: mitochondrial replacement techniques. Now both 
the technologic barriers as well as the policy barriers for MRT are considerably lowered, 
at least in the UK, the first clinical use is expected shortly. This would encompass a 
modification of the mitochondrial genome. 
Second, recent advances in genome editing techniques such as CRISPR/Cas9 
make it possible to edit DNA sequences in virtually any organism of choice. In April 2015, 
Chinese scientists published the first report of the use of gene editing techniques for 
basic research in human embryos. Gene editing experiments in human embryos have 
now been approved in China, the UK and Sweden. 
These developments have sparked an international ethical debate. Leading 
scientific journals Nature and Science rejected the first Chinese publication for ethical 
reasons and published commentaries that called for an international moratorium. Others 
view the continuation of basic gene editing research on human embryos as a ‘moral 
imperative’ for its offers the future potential of correcting genetic disease, many of which 
are currently untreatable. Many, among which myself as a member of the Hinxton Group, 
emphasized the need for ethical and public deliberation about emerging genome editing 
techniques and (international) oversight. 
In this presentation I will present a very short history of one year germline 
genome editing research and debate, followed by three observations for ethics and 
governance of germline genome editing.  
 
  
13 
 
 
Bio  
 
Dr Annelien L. Bredenoord (1979) is an Associate Professor of Medical Ethics at the 
University Medical Center Utrecht, The Netherlands as well as member of the Dutch 
Senate (First Chamber) on behalf of D66.  
 
She obtained degrees in Theology and Political Sciences at Leiden University. In her PhD 
thesis at Maastricht University she examined ethical challenges at the crossroads of 
reproductive medicine and genetic technology. As of 2009, Annelien is an associate 
professor at the University Medical Center Utrecht. In her research, education and 
translational activities she examines and evaluates the ethical issues raised by biomedical 
innovation, particularly in the interrelated fields of (1) Regenerative Medicine, stem cells 
and organoid technology, (2) biobanking and Big Data and (3) genetics/genomics. How to 
translate biomedical innovations from basic research into clinical care and society in an 
ethically sound way?  
 
Annelien published widely in this field,  and is supervisor of several PhD students and 
graduate students. She obtained a ZonMw VENI grant to study the ethics of stem cell 
research and her current projects are financed by ZonMw and Dutch Cancer Society KWF.  
 
Annelien is member of several (inter)national committees among which the Ethics 
Committee of the International Society for Stem Cell Research (ISSCR), the Ethics 
Working Party of the International Stem Cell Forum, the Scientific Board of the European 
Meeting on Psycho-Social Aspects of Genetics, the Young Academy of the Royal 
Netherlands Society for Arts and Sciences, the Dutch National Indication Committee 
Preimplantation Genetic Diagnosis, the scientific advisory board of l’Oreal UNESCO 
Women in Science Program, the scientific advisory board of NIAS Lorentz Program and 
UMC Utrecht's Research Ethics Committee. She is frequently invited as a guest in Dutch 
popular media.  
 
As of june 2015 Bredenoord is member of Dutch Senate on behalf of D66. Her portfolios 
are health care, privacy, data protection, and family law. 
 
Contact data 
University Medical Center Utrecht    
Julius Center, department of Medical Humanities      
Stratenum, internal post 6.131   
P.O. Box 85500, 3508 GA Utrecht, The Netherlands      
Phone: +31 64 107 4365 
Email: A.L.Bredenoord@umcutrecht.nl  
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Professor Emeritus, John Harris  
 
“Gene Editing, Future People and Future Worlds” 
 
Abstract 
At least two genetic technologies capable of making 
heritable changes to the human genome  have revived 
interest in, and in some quarters a very familiar panic 
concerning, so-called germline interventions.  These 
technologies are:   CRISPR/Cas9 to edit genes in non-viable 
IVF zygotes and Mitochondrial Replacement Therapy (MRT)  
approved in principle in a landmark vote by the United 
Kingdom Parliament in 2015.  The possibility of using either 
of these techniques in humans has encountered the most violent  hostility and suspicion. 
However  to understand this hostility and to see whether or not it is justified, we need to 
start by reflecting on the birth of two British girls born roughly twenty  years apart between 
1978 and 1997.  
 
Bio 
John Harris  FMedSci., Member, Academia Europaea., FRSA.,  B.A., D.Phil., Hon. D.Litt. is 
Emeritus Professor of Bioethics, University of Manchester.  Books  Include: The Value of Life, 
Routledge 1985. Wonderwoman and Superman, Oxford University Press 1992.,Clones Genes and 
Immortality. Oxford University Press, 1998.  John Harris Ed. Bioethics. Oxford Readings in 
Philosophy Series, Oxford University Press. 2001. Justine C. Burley and John Harris Eds. A 
Companion To Genethics:  philosophy and the genetic revolution. Basil Blackwell, Oxford. 2002. 
 Blackwell’s Companions to Philosophy series , On Cloning,  Routledge. London, 2004. Enhancing 
Evolution Princeton University Press 2007 and How to be Good. Oxford University Press 2016. 
John Harris is the author or editor of twenty-one books and over three hundred and fifty 
papers.  
 
Since 2012 John Harris has been writing about, and advocating for, a liberalization of  
attitudes to gene editing and germline interventions.  He first wrote publicly about this 
specific issue in  The Guardian  newspaper 19th September 2012,  shortly after The U.K. 
Human Fertilization and Embryology Authority announced a public consultation on 
mitochondrial DNA transfer. He spoke in the United Kingdom Parliament,  Monday 2nd 
February 2015 (on the eve of the historic debate and vote in the U.K. Parliament that gave 
the go-ahead to mitochondrial transfer in humans). He was invited to make a presentation  at 
A workshop of the United States Institute of Medicine of the National Academies Board on 
Health Sciences Policy, held March 31st to April 1st 2015  entitled “Ethical and Social Policy 
Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial 
DNA Diseases”. Washington, http://www.iom.edu/Activities/Research/MitoEthics/2015-
MAR-31.aspx.   
He was invited  by David Baltimore, chair, and the members of the International Summit 
Planning Committee on Human Gene Editing, to speak at the Summit held at the National 
Academy of Sciences in Washington, DC, on December 1-3, 2015. Harris summarised what he 
said at  this meeting in an Op Ed in the  Financial Times on January 15, 2016. 
http://www.ft.com/cms/s/0/9fd0529e-bb6a-11e5-b151-8e15c9a029fb.html. John Harris is a 
founder member of The Hinxton Group whose report entitled Statement on Genome Editing 
Technologies and Human Germ line Genetic Modification was published (10th September 
2015.) 
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10.45 – 11.00 Intermezzo by  guitar-player Hafez Ismaili M’hamdi 
 
                                                               
Hafez Ismaili M’hamdi  
 
Bio    
 Hafez Ismaili M’hamdi ( 1981) is PhD candidate at  
 Erasmus MC department 
of Medical Ethics and Philosophy. 
Lecturer Philosophy of  Music and Aesthetics at Leiden University. 
Professional musician specialized in Jazz and Flamenco.   
16 
 
 
 
Dr. Saskia Nagel 
 
 
“An era of (neuro-) technological self-shaping and 
imperatives of self-determination - the value of autonomy 
support” 
 
Abstract 
Neurosciences and technological developments offer a plethora of 
interventions for self-control and self-shaping. Intentionally monitoring and shaping the body 
to improve capacities puts body and mind at the individual’s disposal more than ever before. 
This has consequences, positive or negative, for our understanding of autonomy, 
responsibility, and our well-being. I will present current self-shaping technologies targeting 
different life phases and discuss the challenges of  “imperatives of self-determination“. I 
suggest an approach to autonomy that avoids balancing acts between paternalism and 
respect for autonomy, and is relevant for debates on decision-making and responsibility, in 
particular concerning new and emerging technologies. 
 
Bio  
Saskia Nagel is an assistant professor for Philosophy and Ethics of Technology (on tenure-
track) at the Department of Philosophy at the University of Twente. She holds an MSc in 
Cognitive Science and a doctoral degree in cognitive science and philosophy (University of 
Osnabrück, Germany).  
Dr.Nagel is working at the intersection of ethics, philosophy, life sciences (in particular 
neurosciences and cognitive science), and technologies. She has developed approaches to 
individual and societal challenges in a technological culture, with a focus on the ethical, 
anthropological, and social consequences of neuroscientific progress. She is particularly 
interested in how technologies influence our self-understanding, and how they impact our 
understanding and perception of autonomy and responsibility. Saskia Nagel combines 
research in applied ethics with philosophy of mind and philosophy of technology and involves 
studies on the public understanding of sciences and technological advances. She seeks to 
understand how emerging (neuro-) technologies help or hinder us flourish throughout life. 
She is a member of the 3TU Centre of Excellence for Ethics and Technology, the Institute of 
Cognitive Science in Osnabrück, the Institute for Interdisciplinary Research in Heidelberg, and 
the National Core for Neuroethics in Vancouver. 
Positions: 
Since Feb. 2016:  Faculty Affiliate at the National Core for Neuroethics at the 
University of British Columbia, Vancouver, CA 
Since Nov. 2014:  Assistant Professor (tenure track) at the University of Twente, 
Netherlands; Department of Philosophy and the Institute for 
Biomedical Technology and Technical Medicine (MIRA) 
Since Jan 2012:   Associated Researcher of the Heidelberg Protestant Institute for 
Interdisciplinary Research 
June-October 2014:  Principal investigator “Cognitive Science and  thics” Institute of 
Cognitive Science (ended when receiving call to Twente) 
2011- 2014:   Head of the Junior  esearch  roup “Changing Brains” funded by 
the German Ministry of Education and Research (BMBF) 
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2009 – 2010:   Postdoc at the Institute of Cognitive Science (Osnabrück) 
2008 - 2009:   Project NeuroSCAN at University Clinics Bonn and Institute for 
Ethics, History, and Theory of Medicine, University of Münster 
 
Educational background: 
2010:    PhD: ” thics and the  eurosciences – The Ethical and Social 
Implications of Monitoring and Manipulating the Brain“,  eferees: 
Prof. W. Lenzen, Prof. P. König, Prof. B. Schöne-Seifert (summa 
cum laude) 
Spring 2006:   Visiting scholar at the Hastings Center for Bioethics, NY, USA 
December 2005:  Master of Science in Cognitive Science with distinction (grade: 1.0) 
Master thesis: “Coherence of human     Signals during crossmodal 
integration of natural stimuli” 
Jun. – Dec. 2003:  Visiting scholar at the Center for Cognitive Science and the 
Department for Philosophy at Rutgers University, NJ, USA 
July 2003:   Bachelor of Science in Cognitive Science with distinction (grade: 
1.0) 
2000 - 2005:   Studies in Cognitive Science and Philosophy at the University of 
Osnabrück 
1999 - 2000:   Studium Generale at the Leibniz Kolleg Tübingen 
 
Contact data:  
Dr. Saskia K. Nagel 
https://www.utwente.nl/bms/wijsb/organization/nagel/ 
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Dr. Loredana  Persampieri (Italy) 
 
“Reproductive tourism and surrogacy: new challenges for European values” 
 
Abstract 
Reproductive tourism or fertility tourism involves 
travelling abroad to access a variety of 
commercially provided assisted reproductive 
technologies, among which the international 
surrogacy market is experiencing an increasingly 
global expansion. International regulatory 
heterogeneity is one of the key drivers of the 
phenomenon: the willingness to circumvent 
existing national bans on surrogacy or restrictions 
on who can access this procedure. Moreover, the 
possibility to resort to low-cost surrogacy treatments in developing countries and the growing 
rate of sterility/fertility issues has triggered soaring demand for this type of cross-border 
service.  European countries are directly engaged in this process, particularly as source 
countries of reproductive tourists. A set of medical and legal risks can be devised for the 
parties involved. 
This landscape may present huge challenges for European values, whenever attempts are 
made to reconcile ethical pluralism and conflicting rights at stake. Ethical and legal 
approaches to surrogacy are explored. The goal of this analysis is to understand the extent to 
which this phenomenon can impinge on the implementation of shared values (underpinning 
rights enshrined in the EU Charter of Fundamental Rights) in the future. 
 
Short Biography 
Loredana Persampieri obtained a Degree magna cum laude in Political Science at LUSPIO 
University of  ome and completed an interdisciplinary Master’s Degree Programme in 
European Studies at the University LUISS Guido Carli of Rome in 2010. In 2014, she earned a 
Master’s Degree cum laude in Diplomacy and International Relations and started a PhD 
research project on “the commodification of the human body in the global market: surrogate 
motherhood. Bioethical and biojuridical aspects” at LUMS  University of  ome.  t present, 
alongside this last activity, she teaches philosophy of law and biolaw courses (within an 
International Programme) at the Department of Law, LUMSA University. 
 
Institutional and advisory activities 
Former member of the Scientific Secretariat and International Relations Expert at the Italian 
National Bioethics Committee of the Presidency of the Council of Ministers (2008-2015) 
Member of the Italian Society of Legal Philosophy (2015-present) 
 
Research area:  
Interactions between bioethics, market and law; beginning of life issues (particularly, ethics 
and assisted reproductive technologies, “reproductive tourism” and surrogacy ; global 
bioethics and human rights; gender studies in legal philosophy 
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Dr Eline M. Bunnik 
 
“Nice to meet? Ethical issues surrounding efforts to 
facilitate early access to investigational drugs” 
 
 
Abstract 
When patients have exhausted standard treatment options, 
they may seek access to unapproved, investigational drugs 
through existing regulatory routes, which are not frequently 
employed. The Amsterdam-based company myTomorrows 
aims to facilitate early access to investigational drugs 
by providing information to patients and their treating 
physicians worldwide, by requesting licenses for named-patient programmes from national 
health authorities, by distributing drugs, collecting data and arranging pharmacovigilance. 
These and other recent efforts to expand early access raise ethical issues, ranging from the 
fostering of false hope and funding issues to the concern that current systems of drug 
development and registration may be undermined.  
 
Bio 
Eline M. Bunnik, PhD, is a postdoctoral researcher at the Department of Medical Ethics and 
Philosophy of Medicine of Erasmus MC, University Medical Centre Rotterdam, the 
Netherlands. She wrote her thesis on ethical issues in genomic testing. Eline is currently 
leading two research projects on ethical issues in non-invase prenatal testing (NIPT), which 
were funded by ZonMw and MRace, and one in which she maps ethical and societal issues 
surrounding efforts to expand access to unapproved, investigational drugs for patients with 
unmet medical needs, which was funded by the Responsible Innovation programme at NWO. 
Starting in July 2016, Eline will develop guidelines for the detection, management and 
communication of incidental findings for BBMRI. She teaches medical ethics at Erasmus MC 
and LUMC.   
 
 
 
 
